Business Wire (press release) Global Market Report of Candesartan cilexetil (CAS 145040-37-5) aims at providing comprehensive data on Candesartan cilexetil globally and regionally (Europe, Asia, North America, Latin America etc.). It captures Candesartan cilexetil market trends ... and more »
FiercePharma Manufacturing According to the FDA's most recent Enforcement Report, Sandoz initiated a Class III voluntary recall of 6,336 bottles of candesartan cilexetil after testing at 18 months found the drug contained more impurities than specification allows. In Class III ...
Pittsburgh Post Gazette Sandoz is recalling one lot of candesartan cilexetil 16 mg. tablets made by Mylan Laboratories in India because of a failed impurities test, according to the latest enforcement report from the Food and Drug Administration. Candesartan cilexetil is used ... and more »
7thSpace Interactive (press release) We therefore hypothesized that patients with hypertension treated with an angiotensin II receptor blocker ( candesartan ) would probably have an increased response to sodium-dependent glucose cotransporter inhibitor therapy (ipragliflozin) compared with ...
Science World Report In a collaborative effort, researchers from St. Olavs Hospital in Trondheim, Norway and the Norwegian University of Science and Technology (NTNU) ha...
Drug Discovery & Development Takeda Pharmaceutical Co. Ltd. received notice of sanctions imposed by the Japan Pharmaceutical Manufacturers Association (JPMA) for promotional activities regarding Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J). The sanctions ...
Medscape BOSTON — The angiotensin receptor blocker candesartan (Atacand, AstraZeneca Pharmaceuticals LP) is safe and as effective as the beta blocker propranolol in preventing migraine headaches, according to a new study. The results of the randomized, ...
